Research Topics
Species | J Alfred WitjesSummaryAffiliation: Radboud University Nijmegen Medical Centre Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigsJ A Witjes
Department of Urology, University Medical Center St Radboud, P O Box 9101, 6500 HB Nijmegen, The Netherlands
Eur Urol 44:615-9. 2003..It has been shown to be effective and well tolerated when given systemically. We investigated the use of this agent administered intravesically in pigs for histological studies of the bladder and pharmacokinetic research...
Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term resultsJ Alfred Witjes
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 53:45-52. 2008..Review adjuvant intravesical pharmacotherapy for non-muscle-invasive bladder cancer (NMIBC), emphasising treatment schedules and long-term results...
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trialRianne J M Lammers
CuraTrial Site Management Organisation and Research, Arnhem, The Netherlands
J Clin Oncol 30:2273-9. 2012..Keyhole limpet hemocyanin (KLH) was beneficial in earlier studies. In this study, safety and efficacy of KLH were compared with that of mitomycin (MM)...
Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancerKees Hendricksen
Department of Urology, Radboud University Nijmegen Medical Centre, Inter Mail 659, PO Box 9101, Nijmegen 6500 HB, The Netherlands
World J Urol 27:337-42. 2009..To study the time-to-recurrence and duration of response in non-muscle invasive bladder cancer (NMIBC) patients, with a complete ablative response after intravesical apaziquone instillations...
Intravesical chemotherapy for superficial bladder cancerJ Alfred Witjes
Department of Urology at University Medical Center Nijmegen, The Netherlands
Nat Clin Pract Urol 1:56-7. 2004
The impact of obesity on prostate cancerJoep G H van Roermund
Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
World J Urol 25:491-7. 2007..Obesity is a growing problem, however, the exact role in the development and progression of PC has not been elucidated. Regarding the optimal treatment of PC in obese patients, comparative prospective studies are needed...
Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a surveyJ A Witjes
Dept of Urology, Radboud University Nijmegen Medical Centre, The Netherlands
Eur Urol 49:478-84. 2006..The purpose of this study is to get insight in the current way urologists diagnose, treat and follow patients with superficial bladder cancer...
Apaziquone for non-muscle invasive bladder cancer: a critical reviewJ Alfred Witjes
Radboud University Nijmegen Medical Centre, Department of Urology 659, PO Box 9101, 6500 H B Nijmegen, The Netherlands
Expert Opin Investig Drugs 17:1085-96. 2008..To describe clinical needs in non-muscle invasive bladder cancer (NMIBC) and review the potential of apaziquone in this respect...
[In favour of open versus laparoscopic prostatectomy]J A Witjes
Universitair Medisch Centrum St Radboud, afd Urologie, Postbus 9101, 6500 HB Nijmegen
Ned Tijdschr Geneeskd 150:139. 2006..Postoperatively, many patients appear to have T3 tumours, which cannot be optimally detected with current imaging techniques. Therefore, an open operation remains preferable...
Management of BCG failures in superficial bladder cancer: a reviewJohannes A Witjes
Department of Urology, University Medical Centre St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Eur Urol 49:790-7. 2006..Review management of bacillus Calmette-Guérin (BCG) failures in superficial bladder cancer...
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancerJ Alfred Witjes
Department of Urology, University Medical Centre, St Radboud, Nijmegen, The Netherlands
Nat Clin Pract Urol 4:542-9. 2007..Long-term studies in this area with HAL are ongoing. The technique is well tolerated and is a useful adjunct to white-light cystoscopy...
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?J Alfred Witjes
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Urol Oncol 27:322-4. 2009..Is there a role for intravesical chemotherapy in a patient who has a first recurrence of a T1G3 bladder cancer?..
Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working partyJ Alfred Witjes
Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands
World J Urol 27:319-24. 2009..To study the results of chemotherapy combined with intravesical hyperthermia in patients with mainly BCG-failing carcinoma in situ (CIS)...
A multicenter, double-blind, randomized, parallel group study comparing polyvinyl chloride and polyvinyl chloride-free catheter materialsJ A Witjes
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Urol 182:2794-8. 2009....
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes
UMC St Radboud, Netherlands, Nijmegen, The Netherlands
Eur Urol 57:607-14. 2010..There is currently no overall European consensus outlining specifically where hexaminolevulinate is or is not indicated...
Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapyBarthold Ph Schrier
Department of Urology 426, University Medical Centre, St Radboud, Geert Grooteplein 10, P O Box 9101, 6500 HB Nijmegen, The Netherlands
Eur Urol 45:292-6. 2004..To evaluate the difference in prognosis between progressive and primary muscle-invasive bladder cancer...
Contemporary management of low-risk bladder cancerJohannes Falke
Radboud University Nijmegen Medical Center, Department of Urology 659, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Nat Rev Urol 8:42-9. 2011..In the future this profiling will play an important role in the timing and the choice of treatment, as well as guiding follow-up procedures...
Review pathology in a diagnostic bladder cancer trial: effect of patient risk categoryJ A Witjes
Department of Urology, University Medical Centre St Radboud, Nijmegen, The Netherlands
Urology 67:751-5. 2006..Review pathology might be an answer, but appears to be of limited value. We studied the effect of patients' risk profile on the value of review pathology...
DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancerDaphne Hessels
Department of Experimental Urology, Nijmegen Center for Molecular Life Sciences, P O Box 9101, 6500 HB Nijmegen, The Netherlands
Eur Urol 44:8-15; discussion 15-6. 2003..DD3(PCA3) is the most prostate cancer-specific gene described to date. To assess the clinical utility of DD3(PCA3) a time-resolved fluorescence-based, quantitative RT-PCR analysis for DD3(PCA3) was developed...
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort studyRoel A M Heesakkers
Department of Radiology, Radboud University Medical Centre, Nijmegen, Netherlands
Lancet Oncol 9:850-6. 2008..In this prospective, multicentre cohort study, we aimed to compare the diagnostic accuracy of MRL with up-to-date multidetector CT (MDCT), and test the hypothesis that a negative MRL finding obviates the need for a PLND...
Impact of obesity on surgical outcomes following open radical prostatectomyJoep G H van Roermund
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Urol Int 82:256-61. 2009..It is unknown whether obesity affects the surgical and oncological outcomes following open radical retropubic prostatectomy (RRP). Knowledge concerning this issue is relevant when counselling obese patients with PCa for RRP...
The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulationsHarm C Arentsen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Urol Oncol 30:64-8. 2012..The objective of this study was to assess antitumor activity and safety of 3 different formulations of intravesical apaziquone in an orthotopic rat bladder cancer model...
Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancerDieuwertje E G Kok
Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
World J Urol 29:695-701. 2011..To determine the effect of body mass index (BMI) on clinical and pathological characteristics at time of diagnosis and on risk of biochemical recurrence after radical prostatectomy among Dutch men diagnosed with prostate cancer...
Molecular markers for detection, surveillance and prognostication of bladder cancerOlaf P J Vrooman
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Urol 16:234-43. 2009..Currently, there are not clinically usable molecular markers that can guide us in diagnosis or surveillance, nor guide us in lowering the frequency of urethrocystoscopy in bladder cancer...
Molecular PCA3 diagnostics on prostatic fluidMartijn P M Q van Gils
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Prostate 67:881-7. 2007..In this study, we evaluated the PCA3 test on prostatic fluid and compared this with the PCA3 test on urine in a clinical research setting...
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker responseAntoine G van der Heijden
University Medical Centre Nijmegen, Nijmegen, The Netherlands
J Urol 176:1349-53; discussion 1353. 2006..Local side effects were comparable to side effects due to other chemotherapy instillations...
Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomyJoep G H van Roermund
Department of Urology, University Medical Center Utrecht, The Netherlands
BJU Int 104:321-5. 2009....
Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostateJurgen J Futterer
Department of Radiology, University Medical Center Nijmegen, Nijmegen The Netherlands
Invest Radiol 39:671-80. 2004..We sought to explore the feasibility of magnetic resonance imaging (MRI) of the prostate at 3T, with the knowledge of potential drawbacks of MRI at high field strengths...
The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative studyEmile N J Th van Lin
Department of Radiation Oncology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
Int J Radiat Oncol Biol Phys 61:278-88. 2005..To investigate the effect of an endorectal balloon (ERB) and an off-line correction protocol on the day-to-day, interfraction prostate gland motion, in patients receiving external beam radiotherapy for prostate cancer...
Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3TStijn W T P J Heijmink
Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Radiat Oncol Biol Phys 73:1446-53. 2009..To determine the changes in prostate shape and volume after the introduction of an endorectal coil (ERC) by means of magnetic resonance imaging (MRI) at 3T...
High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsiesJack J A van Asten
Department of Radiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
MAGMA 21:435-42. 2008..Here, we demonstrate the use of non-destructive high resolution magic angle spinning (HRMAS) proton NMR Spectroscopy for the assessment of metabolic profiles of prostate tissue in PNBs as commonly obtained in standard clinical practice...
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibilityThomas Hambrock
Department of Radiology, University Medical Centre Nijmegen, Nijmegen, Netherlands
Invest Radiol 43:686-94. 2008..Furthermore, to evaluate the practicability of MR-guided biopsy on a 3T MR scanner using a 32-channel coil and a MR-compatible biopsy device...
Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissueCornelis G van Niekerk
Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Prostate 69:62-9. 2009..Aim of this study was to investigate whether microvascularity is increased in prostate confined cancer (pT2)...
A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant"I M van Oort
Department of Urology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Urol Oncol 27:509-13. 2009..5 cc and Gleason scores <7, InsigPC) are considered clinically insignificant by some investigators. The aim of this study is to determine the biochemical recurrence rate (BCR) of svPC and InsigPC in prostatectomy specimens...
Site-specific familial aggregation of prostate cancerBas A J Verhage
Center for Prevention and Health Services Research PZO, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Int J Cancer 109:611-7. 2004..5; 95% CI = 1.7-3.6). Cancers at other sites did not coaggregate with PC. Our data suggest that familial PC, at least in this Western European population, is site-specific, not part of an inherited cancer syndrome...
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imagingWillem M L L G Deserno
Department of Radiology, University Medical Center Sint Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Radiology 233:449-56. 2004..To prospectively evaluate ferumoxtran-10-enhanced magnetic resonance (MR) imaging for nodal staging in patients with urinary bladder cancer...
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund
Department of Urology, University Medical Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands
BJU Int 105:42-8. 2010....
Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trialMartine M Goedendorp
Expert Centre for Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Oncologist 15:1122-32. 2010..The aim of this multicenter randomized controlled trial (RCT) with three conditions was to demonstrate the efficacy and to determine the contribution of physical activity...
Quantitative analysis of lymph vessel characteristics in organ confined prostate cancerCornelis G van Niekerk
Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Prostate 71:91-7. 2011..The objective of this study was to analyze the characteristics of lymphatic vasculature in normal and (peri)tumoral prostate tissue, applying accurate and objective quantification techniques based on digital image analysis...
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancerLambertus A Kiemeney
Department of Epidemiology, Biostatistics and Health Technology Assessment, Nijmegen, The Netherlands
Nat Genet 42:415-9. 2010..The frequency of rs798766[T] is higher in Ta tumors that carry an activating mutation in FGFR3 than in Ta tumors with wild-type FGFR3. Our results show a link between germline variants, somatic mutations of FGFR3 and risk of UBC...
Applicability of biomarkers in the early diagnosis of prostate cancerDaphne Hessels
Center for Molecular Life Sciences, Nijmegen, The Netherlands
Expert Rev Mol Diagn 4:513-26. 2004..This could subsequently lead to a reduction of the number of unnecessary biopsies...
The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performanceMartijn P M Q van Gils
Department of Urology, Radboud University Nijmegen Medical Centre, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands
Clin Cancer Res 13:939-43. 2007..In a previous single institution study, the PCA3 urine test clearly proved to be of diagnostic value. Therefore, the diagnostic performance of the PCA3 urine test was validated in a multicenter study...
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapyDerya Yakar
Department of Radiology, Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands
Invest Radiol 45:121-5. 2010....
Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigenThomas Hambrock
University Medical Centre St Radboud, Nijmegen, The Netherlands
J Urol 183:520-7. 2010..We compared results to those in a matched transrectal ultrasound guided prostate biopsy population. Also, we determined the clinical significance of detected tumors...
Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomasIman J Schultz
Department of Clinical Chemistry, University Medical Center Nijmegen, Nijmegen, The Netherlands
Clin Chem 50:1425-8. 2004
Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancerDaphne Hessels
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Prostate 70:10-6. 2010..In this study, PCA3 was correlated with clinical stage, biopsy Gleason score (GS), radical prostatectomy GS, tumor volume, and pathological stage to assess its potential as predictor of PCa aggressiveness...
Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test resultsMartijn P M Q van Gils
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Prostate 68:1215-22. 2008..PCA3 has proven to be of value in the diagnosis of PCa. However, so far few attempts have been made to investigate the prognostic value of PCA3. Our objective was to further investigate the prognostic value of PCA3...
The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging systemInge M van Oort
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
BJU Int 102:438-41. 2008..To evaluate the prognostic role of the 2002 Tumour-Nodes-Metastasis (TNM) pT2 subclassification for biochemical recurrence (BCR) after radical prostatectomy (RP) for prostate cancer...
Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostateJurgen J Futterer
Department of Radiology, Radboud University Nijmegen Medical Center, The Netherlands
Invest Radiol 42:116-22. 2007..We sought to determine the localization accuracy using 3-dimensional (3D) proton magnetic resonance spectroscopic imaging (MRSI) of the entire prostate with a standardized thresholds approach in prostate cancer patients...
Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imagingJurgen J Futterer
Department of Radiology, University Medical Center Nijmegen, Nijmegen, The Netherlands
Eur Radiol 17:1055-65. 2007..Overstaging is reduced significantly with equal sensitivity when an endorectal-pelvic phased-array coil is used...
Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performanceStijn W T P J Heijmink
Department of Radiology, Radboud University Nijmegen Medical Centre, Geert Grooteplein zuid 10, NL 6500 HB, Nijmegen, The Netherlands
Radiology 244:184-95. 2007....
Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factorsJohan F Langenhuijsen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Radiat Oncol Biol Phys 69:671-6. 2007..To report the complication rate and risk factors of transrectally implanted gold markers, used for prostate position verification and correction procedures...
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancerStijn W T P J Heijmink
Department of Radiology, Radboud University Nijmegen Medical Centre, The Netherlands
Eur Radiol 16:927-38. 2006..Performing colour or contrast-enhanced Doppler biopsy or adding these techniques to systematic biopsies improves diagnostic performance, particularly by increasing sensitivity...
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imagingJurgen J Futterer
Department of Radiology, Radboud University Nijmegen Medical Center, Geert Grooteplein zuid 10, NL 6500 HB, Nijmegen, The Netherlands
Radiology 241:449-58. 2006....
Prostate cancer: local staging at 3-T endorectal MR imaging--early experienceJurgen J Futterer
Department of Radiology, University Medical Center Nijmegen, Geert Grooteplein zuid 10, NL 6500 HB, Nijmegen, The Netherlands
Radiology 238:184-91. 2006..To prospectively investigate the local staging accuracy of 3-T endorectal magnetic resonance (MR) imaging for prostate cancer by using whole-mount-section histopathologic analysis as the standard of reference...
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRIEmile N J T van Lin
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Radiat Oncol Biol Phys 65:291-303. 2006....
Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readersJurgen J Futterer
Department of Radiology, University Medical Center Nijmegen, The Netherlands
Radiology 237:541-9. 2005....
Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibilityTom W J Scheenen
Department of Radiology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands
Radiology 245:507-16. 2007....
CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomasIman J Schultz
Department of Clinical Chemistry, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Int J Cancer 116:282-4. 2005..Our results suggest, in contrast to those of Guo et al. (Nat Med 2004;10:374-81), that the oncogene CDC91L1 is not overexpressed at the mRNA level in urothelial cell carcinomas and cannot be used to predict the course of the disease...
Experimental rat bladder urothelial cell carcinoma modelsHarm C Arentsen
Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands
World J Urol 27:313-7. 2009..In the second part of the paper the development of a potential new orthotopic rat bladder tumor model is described...
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancerKees Hendricksen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 53:984-91. 2008....
Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrenceIman J Schultz
Departments of Clinical Chemistry, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Anticancer Res 27:1051-8. 2007..The prediction of tumor recurrence in patients with Ta urothelial cell carcinoma is inaccurate and new prognostic markers are desirable...
No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridizationLambertus A Kiemeney
Department of Urology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands
Cancer Epidemiol Biomarkers Prev 15:180-3. 2006
Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapyRuben G H M Cremers
Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, The Netherlands
Radiother Oncol 97:467-73. 2010....
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic reviewSven van den Bosch
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 60:493-500. 2011..Some studies report that tumour progression in patients with non-muscle-invasive bladder cancer (NMIBC) is associated with a poor prognosis. However, no systematic evidence is available...
Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapyJohan F Langenhuijsen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Urol Oncol 29:52-7. 2011..The optimal duration of hormonal treatment, however, is unknown. The endpoint of this study is the optimal duration of androgen deprivation for prostate volume reduction in a cohort of patients scheduled for external beam radiotherapy...
Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer RegistryMartine Ploeg
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Urol 183:915-20. 2010..Nonurothelial malignancies represent a small fraction of bladder malignancies and are less extensively studied, resulting in sparse empirical data on these tumors. We sought insight into tumor characteristics and survival...
Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissuesPaul N Span
Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
BJU Int 102:177-82. 2008....
Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysisHilco van Moerkerk
Department of Urology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands
Eur Urol 50:762-8; discussion 768-9. 2006..03. CONCLUSION: Semiautomatic localization based on clustering analysis of blood flow aids in localization of prostate tumors. A clustering map is an easy-to-interpret extension to standard power Doppler images...
Intravesical gemcitabine: an update of clinical resultsKees Hendricksen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Curr Opin Urol 16:361-6. 2006..Exploring phase-II and comparative randomized phase-III studies should provide additional information on gemcitabine and its benefit to clinical practice...
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinomaIman J Schultz
Department of Clinical Chemistry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 51:416-22; discussion 422-3. 2007..This study aims at discriminating between patients with primary Ta UCC and long or short recurrence-free periods...
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysisAntoine G van der Heijden
Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands
World J Urol 25:303-8. 2007..Seven out of nine patients treated with hyperthermia showed a decrease in p53 activity. A decrease in proliferation activity and p53 activity illustrate the potential role of thermo-chemotherapy as a promising intravesical treatment...
Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivinIman J Schultz
Department of Clinical Chemistry, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands
Clin Chim Acta 368:20-32. 2006..Also, important requirements for a successful implementation of such markers in a hospital setting are discussed. Finally, future directions for the discovery of new diagnostic or prognostic candidate markers will be mentioned...
Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancerKees Hendricksen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Curr Opin Urol 17:352-7. 2007..We discuss options for first-line and second-line adjuvant therapy for nonmuscle invasive bladder cancer...
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyAntoine G van der Heijden
Department of Urology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
J Urol 173:1375-80. 2005..Hyperthermia alone did not cause decreased cell proliferation. Synergism was most prominent with low drug doses and the most potent drug used in this in vitro study was EO9...
Polymorphisms in the H19 gene and the risk of bladder cancerGerald W Verhaegh
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 54:1118-26. 2008..In this study we examined whether sequence variants within the H19 gene are associated with the risk of developing bladder cancer...
The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinomaIman J Schultz
Department of Clinical Chemistry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Anticancer Res 27:1025-30. 2007..The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression was investigated in patients with urothelial cell carcinoma (UCC)...
Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancerPaula M J Moonen
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Eur Urol 52:464-8. 2007..We aimed to study the association between presence of (high-risk) HPV DNA, p53 status, and clinical outcome in bladder cancer patients. This study must be seen as a preliminary study to investigate this potentially important problem...
Screening for prostate cancer in Dutch hereditary prostate cancer familiesLambertus A Kiemeney
Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Cancer 122:871-6. 2008..We suggest that the same PSA testing guidelines should apply to HPC families and the general population. A more aggressive screening policy in HPC families does not seem to be justified...
